Wall Street expects a year-over-year increase in earnings on higher revenues when Inogen (INGN) reports results for the quarter ended December 2025. While this widely-known consensus outlook is ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Home respiratory is a cornerstone of the HME industry, but manufacturers and providers are redefining what success in the market looks like: Oxygen therapy that keeps pace with patients, durable ...

Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator. The product is now available for sale through the company’s domestic direct-to-consumer sales channel ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of ...

Inogen (INGN) shares soared 6.6% in the last trading session to close at $6.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report third quarter 2025 financial ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

Inogen, Inc. INGN is gaining on its solid product portfolio expansion and strong momentum within European markets. However, forex headwinds have been offsetting the positives to some extent. The ...